Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$394K Buy
3,064
+75
+3% +$8.78K 0.09% 51
2026
Q1
$360K Buy
2,989
+117
+4% +$13.5K 0.1% 48
2025
Q4
$302K Buy
2,872
+55
+2% +$5.16K 0.09% 45
2025
Q3
$236K Buy
2,817
+1,934
+219% +$159K 0.07% 58
2025
Q2
$69.9K Buy
883
+708
+405% +$56.3K 0.02% 156
2025
Q1
$15.7K Sell
175
-683
-80% -$63.8K 0.01% 379
2024
Q4
$85.3K Buy
858
+559
+187% +$57.6K 0.03% 84
2024
Q3
$33.9K Sell
299
-1,241
-81% -$147K 0.01% 213
2024
Q2
$191K Buy
1,540
+723
+88% +$93.1K 0.05% 119
2024
Q1
$108K Buy
817
+16
+2% +$1.97K 0.03% 137
2023
Q4
$87.3K Buy
801
+317
+65% +$32.9K 0.02% 137
2023
Q3
$49.8K Hold
484
0.02% 149
2023
Q2
$55.8K Sell
484
-826
-63% -$93.8K 0.02% 150
2023
Q1
$139K Hold
1,310
0.06% 123
2022
Q4
$145K Buy
+1,310
New +$134K 0.07% 113

Other funds holding MRK

True Wealth Design's MRK Position: Q2 2026 in Review

True Wealth Design increased its Merck (MRK) stake by 2.5% in Q2 2026, buying an estimated $8.78K and bringing the position to 3,064 shares worth $394K. The position accounts for 0.09% of the portfolio, ranked #51.

True Wealth Design first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • True Wealth Design held 3,064 shares of Merck worth $394K as of Q2 2026.
  • True Wealth Design bought 75 Merck shares in Q2 2026, an estimated $8.78K.
  • Merck made up 0.09% of True Wealth Design's portfolio in Q2 2026, its #51 holding.
  • True Wealth Design first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.